Disease modification and other trials in systemic sclerosis have come a long way, but have to go further

Arthritis Care Res (Hoboken). 2012 Jul;64(7):955-9. doi: 10.1002/acr.21673.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Antirheumatic Agents / therapeutic use*
  • Clinical Trials as Topic*
  • Humans
  • Randomized Controlled Trials as Topic*
  • Scleroderma, Systemic / drug therapy*

Substances

  • Antirheumatic Agents